30,000 volunteers sought to catch pancreatic cancer early

NCT ID NCT06271291

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find pancreatic cancer earlier in people who are at higher-than-average risk due to family history or genetic mutations. Researchers will collect blood samples and health data from 30,000 participants over time to build a biobank. The goal is to improve early detection, when treatment may be more effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma pancreatic adenocarcinoma pancreatic neoplasm pancreatic ductal adenocarcinoma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
HonorHealth Research Institute
WITHDRAWN

Scottsdale, Arizona, 85258, United States
Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••
OSF Saint Francis Medical Center
RECRUITING

Peoria, Illinois, 61615, United States
Oregon Health & Science University
RECRUITING

Portland, Oregon, 97201, United States
Piedmont Healthcare
RECRUITING

Atlanta, Georgia, 30309, United States
The Johns Hopkins University School of Medicine
RECRUITING

Baltimore, Maryland, 21231, United States
University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198-6805, United States
University of Pittsburgh
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.